These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26962814)

  • 1. Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis.
    Munnee K; Bundhun PK; Quan H; Tang Z
    Medicine (Baltimore); 2016 Mar; 95(10):e3006. PubMed ID: 26962814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery bypass surgery compared with percutaneous coronary interventions in patients with insulin-treated type 2 diabetes mellitus: a systematic review and meta-analysis of 6 randomized controlled trials.
    Bundhun PK; Wu ZJ; Chen MH
    Cardiovasc Diabetol; 2016 Jan; 15():2. PubMed ID: 26739589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the adverse clinical outcomes in patients with non-insulin treated type 2 diabetes mellitus and patients without type 2 diabetes mellitus following percutaneous coronary intervention: a systematic review and meta-analysis.
    Li N; Yang YG; Chen MH
    BMC Cardiovasc Disord; 2016 Nov; 16(1):238. PubMed ID: 27887590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contemporary Outcomes of Coronary Artery Bypass Grafting Among Patients With Insulin-Treated and Non-Insulin-Treated Diabetes.
    Li Z; Amsterdam EA; Young JN; Hoegh H; Armstrong EJ
    Ann Thorac Surg; 2015 Dec; 100(6):2262-9. PubMed ID: 26319487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial.
    Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V;
    J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of type 2 diabetes mellitus on the long-term mortality in patients who were treated by coronary artery bypass surgery: A systematic review and meta-analysis.
    Bundhun PK; Bhurtu A; Yuan J
    Medicine (Baltimore); 2017 Jun; 96(22):e7022. PubMed ID: 28562555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in patients with insulin-treated versus non-insulin-treated diabetes mellitus.
    Hoebers LP; Claessen BE; Woudstra P; DeVries JH; Wykrzykowska JJ; Vis MM; Baan J; Koch KT; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    EuroIntervention; 2014 May; 10(1):90-6. PubMed ID: 24832639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials.
    Bundhun PK; Bhurtu A; Soogund MZ; Long MY
    PLoS One; 2016; 11(4):e0154064. PubMed ID: 27111304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Mellitus and Long-Term Risk for Heart Failure After Coronary Revascularization.
    Takeji Y; Shiomi H; Morimoto T; Furukawa Y; Ehara N; Nakagawa Y; Kato T; Tazaki J; Kato ET; Yaku H; Yoshikawa Y; Tada T; Hanyu M; Kadota K; Komiya T; Ando K; Kimura T;
    Circ J; 2020 Feb; 84(3):471-478. PubMed ID: 31996490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus.
    Noman A; Balasubramaniam K; Alhous MHA; Lee K; Jesudason P; Rashid M; Mamas MA; Zaman AG
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1195-1204. PubMed ID: 28029209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis.
    Bundhun PK; Li N; Chen MH
    Cardiovasc Diabetol; 2015 Oct; 14():135. PubMed ID: 26446829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early (≤ 30 Days), Late (31-360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-Analysis.
    Chen W; Wu Y; Hu Y
    Diabetes Ther; 2018 Jun; 9(3):1113-1124. PubMed ID: 29644619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous coronary intervention in insulin-treated diabetic patients: A meta-analysis.
    Ge Y; He D; Shao Y; Wang L; Yan W
    Ann Noninvasive Electrocardiol; 2022 Sep; 27(5):e12953. PubMed ID: 35467783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass grafting versus percutaneous coronary intervention in patients with noninsulin treated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
    Wang Y; Wen M; Zhou J; Chen Y; Zhang Q
    Diabetes Metab Res Rev; 2018 Jan; 34(1):. PubMed ID: 28921837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era.
    Pi SH; Rhee TM; Lee JM; Hwang D; Park J; Park TK; Yang JH; Song YB; Choi JH; Hahn JY; Kim BJ; Kim BS; Gwon HC; Choi SH
    Am J Cardiol; 2018 Jun; 121(12):1505-1511. PubMed ID: 29751955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Versus Long-Term Adverse Cardiovascular Outcomes Post Percutaneous Coronary Intervention in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Simple Meta-Analysis.
    Lu H; Tang B; Zhou Y; Xu C; Bundhun PK; Tang Z; Bao H
    Diabetes Ther; 2019 Aug; 10(4):1487-1497. PubMed ID: 31256352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated Versus Non-Insulin Treated Diabetes Mellitus.
    Biswas S; Dinh D; Andrianopoulos N; Lefkovits J; Ajani A; Duffy SJ; Chan W; Walton A; Brennan A; Clark DJ; Hiew C; Oqueli E; Reid CM; Stub D; Eccleston D
    Am J Cardiol; 2021 Jun; 148():36-43. PubMed ID: 33667454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of type 2 diabetes mellitus on short- and long-term mortality after coronary artery bypass surgery.
    Kogan A; Ram E; Levin S; Fisman EZ; Tenenbaum A; Raanani E; Sternik L
    Cardiovasc Diabetol; 2018 Nov; 17(1):151. PubMed ID: 30497472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.